Lyell Immunopharma Inc (LYEL) — Free Cash Flow Generation Index
Lyell Immunopharma Inc (LYEL) has a Free Cash Flow Generation Index of 0.59x as of December 2019. Free cash flow of $23.43 Million represents 1% of operating cash flow ($39.47 Million). Read LYEL total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Lyell Immunopharma Inc Free Cash Flow Generation Index (2019–2019)
Historical FCF Generation Index trend for Lyell Immunopharma Inc across 1 annual periods. Explore how much does Lyell Immunopharma Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Lyell Immunopharma Inc (2019–2019)
Year-by-year Free Cash Flow Generation Index for Lyell Immunopharma Inc. For the full company profile including market capitalisation, see Lyell Immunopharma Inc stock valuation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.59x | $23.43 Million | $39.47 Million | $16.05 Million | — |